Dupilumab in Children with Uncontrolled Moderate-to-Severe Asthma
Por um escritor misterioso
Descrição
Dupixent Reduces Asthma Exacerbations in Younger Children
DUPIXENT® (dupilumab) in Moderate-to-Severe Asthma
Assessment of dupilumab in children with moderate‐to‐severe type 2
DUPIXENT® (dupilumab) Pediatric Asthma Efficacy
Dupilumab in Children with Uncontrolled Moderate-to-Severe Asthma
DUPIXENT® (dupilumab) for Moderate-to-Severe Atopic Dermatitis
Dupilumab pharmacokinetics and effect on type 2 biomarkers in
Frontiers Severe pediatric asthma therapy: Dupilumab
New Drug a Good Treatment Option for Severe Asthma in Kids
How DUPIXENT® (dupilumab) is Taken: Asthma Dosing
FDA Accepts Dupixent® (dupilumab) for Priority Review in Children
Frontiers Dupilumab efficacy and safety in patients with
Dupilumab reduces attacks and improves lung function in asthmatic
de
por adulto (o preço varia de acordo com o tamanho do grupo)
